Pharmacy Times August 18, 2023
Alana Hippensteele, Managing Editor

Opportunities for an additional specialization in molecular pathology may be helpful to train professionals in the real-time interpretation of gene therapy test results.

Following the advent of precision medicine, the oncology field shifted dramatically over the next 10 years, explained John Marshall, MD, Clinical Director of Oncology for Georgetown University, during a panel discussion at the 2023 NCODA Oncology Institute. Ten years ago, immunotherapies were thought of as ridiculous, and were placed in the back alley of ASCO in the 400 section.

“Now, [immunotherapy research] is in the poster discussion section, and you need a tractor pull room to just talk about the latest postings,” Marshall said. “[Further], 10 years ago, gene therapy testing was quite unusual. You had to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma / Biotech, Precision Medicine
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Patient-derived organoids: Transforming cancer research and personalized medicine

Share This Article